Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.

Psychiatry Clin Neurosci · 2020 · PMC7027855 · PMID 31725942

Europe PMC DOI

hedged sentence

0.0609

closest p · 1.2× alpha

0.0609

boldest claim

The sentences

did not reach statistical significanceP = 0.0609so close (0.05 < p ≤ 0.1)

A significant improvement in CGI‐S score was observed in subjects administered vortioxetine 20 mg, but this did not reach statistical significance for the 10 mg dose ( P = 0.0609).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.